Evidence map›Paper›PMID 40952595›Full record

ReviewMolecular biology reports2025

Beyond inflammation: a comprehensive microglial regulation model in chronic pain.

Yu Lei, Qian Wang, Feixiang Wang, Guo Mu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu LeiDepartment of Anesthesiology, Guangyuan Central Hospital, Guangyuan, 628000, Sichuan, China.
Qian WangDepartment of Anesthesiology, Guangyuan Central Hospital, Guangyuan, 628000, Sichuan, China.
Feixiang WangDepartment of Anesthesiology, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, China.
Guo MuDepartment of Anesthesiology, Zigong Fourth People's Hospital, No.19 Tanmulin Street, Ziliujing District, Zigong, 643000, China. muguo@zg120.cn.

Funding

Wu Jieping Foundation Special Research Project on Optimal Management of Acute Pain No. 310.6750.2024-15-7Zigong Key Science and Technology Plan (Collaborative Innovation Project of Zigong Institute of Brain Sciences No.2024-NKX-01-02 and 2022ZCNKY01
6 · The paper itself

Abstract

Chronic pain has emerged as a disorder of persistent neuroimmune dysregulation, with microglia playing a pivotal role in shaping maladaptive plasticity. Beyond classical inflammatory pathways, recent discoveries highlight microglial involvement in epigenetic remodeling, metabolic reprogramming, and synaptic modulation. These multidimensional processes sustain microglial activation and promote central sensitization, even in the absence of ongoing peripheral injury. This review proposes a comprehensive framework for understanding microglial regulation in chronic pain, emphasizing the failure of immune tolerance, aberrant neuron-glia signaling, and the emergence of disease-perpetuating microglial states. We further discuss therapeutic strategies aimed at selectively targeting microglial phenotypes, including HDAC inhibitors, metabolic modulators, and pathway-specific antagonists. By integrating mechanistic depth with translational insights, this review reframes microglia not only as inflammatory mediators, but as dynamic regulators whose dysregulation underlies pain chronification.

Indexed as

Chronic PainInflammationMicrogliaAnimalsHumansNeuronsSignal TransductionChronic painEpigeneticsMetabolismMicrogliaNeuroimmune regulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.